Utama › Leukemia-Limfoma Limfoblastik Sel-T Pendahulu › Ohio
Kajian klinikal Leukemia-Limfoma Limfoblastik Sel-T Pendahulu di Ohio
6 kajian untuk Leukemia-Limfoma Limfoblastik Sel-T Pendahulu sedang mencari peserta di lokasi di Ohio.
Bandar di Ohio
Teks kajian rasmi (Bahasa Inggeris)
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Oncology Hematology Care, Cincinnati
- Cincinnati Children's Hospital Medical Center, Cincinnati
Mengambil pesertaFasa 2
6 Months · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06514794Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Ohio State University Comprehensive Cancer Center, Columbus
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT04301076Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
- Nationwide Children's Hosptial, Columbus
Mengambil pesertaFasa 1
Sehingga umur 39 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT04972942A Registry for People With T-cell Lymphoma
- Ohio State University (Data Collection Only), Columbus
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 20 Mei 2026 · NCT05978141Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
- Ohio State University Comprehensive Cancer Center, Columbus
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Apr 2026 · NCT07356245Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
- Ohio State University Comprehensive Cancer Center, Columbus
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Feb 2026 · NCT04848064Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.